{"filing": {"accession": "0001601830-26-000078", "cik": "0001601830", "ticker": "RXRX", "company_name": "RECURSION PHARMACEUTICALS, INC.", "form_type": "10-Q", "filing_type": "10-Q", "filing_date": "2026-05-06", "accepted_datetime": null, "acceptance_datetime": null, "accepted_at": null, "primary_doc_url": "https://www.sec.gov/Archives/edgar/data/1601830/000160183026000078/0001601830-26-000078-index.htm", "filing_url": "https://www.sec.gov/Archives/edgar/data/1601830/000160183026000078/0001601830-26-000078-index.htm", "period_of_report": "2026-03-31"}, "html_url": "/api/filings/000160183026000078/stream", "exhibits": [{"exhibit_number": "31.1", "exhibit_type": "31", "description": "Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.", "filename": "exhibit311-q0126.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1601830/000160183026000078/exhibit311-q0126.htm", "category": "other", "incorporated_by_reference": false}, {"exhibit_number": "31.2", "exhibit_type": "31", "description": "Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.", "filename": "exhibit312-q0126.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1601830/000160183026000078/exhibit312-q0126.htm", "category": "other", "incorporated_by_reference": false}, {"exhibit_number": "32.1", "exhibit_type": "32", "description": "Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.", "filename": "exhibit321-q0126.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1601830/000160183026000078/exhibit321-q0126.htm", "category": "other", "incorporated_by_reference": false}, {"exhibit_number": "2.1", "exhibit_type": "2", "description": "Transaction Agreement by and between Recursion Pharmaceuticals, Inc. and Exscientia plc dated as of August 8, 2024.", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1601830/000119312524196505/d856792dex21.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "3.1", "exhibit_type": "3", "description": "Amended and Restated Certificate of Incorporation of Recursion Pharmaceuticals, Inc.", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/0001601830/000119312521123764/d149444dex31.htm", "category": "incorporation", "incorporated_by_reference": true}, {"exhibit_number": "3.2", "exhibit_type": "3", "description": "Amended and Restated Bylaws of Recursion Pharmaceuticals, Inc.", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1601830/000160183024000009/a1-25x24amendedbylaws.htm", "category": "incorporation", "incorporated_by_reference": true}, {"exhibit_number": "4.1", "exhibit_type": "4", "description": "Specimen Class A common stock certificate of the Registrant.", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/0001601830/000119312521089610/d89478dex42.htm", "category": "other", "incorporated_by_reference": true}, {"exhibit_number": "4.2", "exhibit_type": "4", "description": "Exchangeable Share Support Agreement, dated May 8, 2023.", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1601830/000160183023000036/exhibit42-valencexexchange.htm", "category": "debt", "incorporated_by_reference": true}, {"exhibit_number": "4.3", "exhibit_type": "4", "description": "Registration Rights Agreement, dated October 24, 2022, by and among the Company and the Purchasers.", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1601830/000119312522268003/d365090dex102.htm", "category": "debt", "incorporated_by_reference": true}, {"exhibit_number": "4.4", "exhibit_type": "4", "description": "Registration Agreement, dated May 16, 2023, by and among the Registrant, Valence Discovery, Inc., and certain shareholders of Valence Discovery, Inc.", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1601830/000160183023000036/exhibit43-valencexregistra.htm", "category": "debt", "incorporated_by_reference": true}, {"exhibit_number": "4.5", "exhibit_type": "4", "description": "Registration Agreement, dated May 25, 2023, by and among the Registrant, Recursion Canada Inc., and certain shareholders of Cyclica Inc.", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1601830/000160183023000044/exhibit41registrationagree.htm", "category": "debt", "incorporated_by_reference": true}, {"exhibit_number": "4.6", "exhibit_type": "4", "description": "Registration Rights Agreement, dated July 11, 2023, by and among the Registrant and NVIDIA.", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1601830/000160183023000050/ex102-rxrxxnvidiaregrights.htm", "category": "debt", "incorporated_by_reference": true}], "sections": [{"section_name": "part_1_item_1", "section_title": "Financial Statements (unaudited)", "start_position": 13651, "end_position": 62818}, {"section_name": "part_1_item_2", "section_title": "Management's Discussion and Analysis of Financial Condition and Results of Operations", "start_position": 62818, "end_position": 88346}, {"section_name": "part_1_item_3", "section_title": "Quantitative and Qualitative Disclosures About Market Risk", "start_position": 88346, "end_position": 89798}, {"section_name": "part_1_item_4", "section_title": "Controls and Procedures", "start_position": 89798, "end_position": 94981}, {"section_name": "part_2_item_1", "section_title": "Legal Proceedings", "start_position": 94981, "end_position": 95430}, {"section_name": "part_2_item_1a", "section_title": "Risk Factors", "start_position": 95430, "end_position": 95672}, {"section_name": "part_2_item_2", "section_title": "Unregistered Sales of Equity Securities and Use of Proceeds", "start_position": 95672, "end_position": 96832}, {"section_name": "part_2_item_6", "section_title": "Exhibits", "start_position": 96832, "end_position": 100837}], "tables": [{"table_index": 0, "table_type": "text", "caption": null, "header_text": ""}, {"table_index": 1, "table_type": "text", "caption": null, "header_text": ""}, {"table_index": 2, "table_type": "text", "caption": null, "header_text": ""}, {"table_index": 3, "table_type": "text", "caption": null, "header_text": ""}, {"table_index": 4, "table_type": "text", "caption": null, "header_text": ""}, {"table_index": 5, "table_type": "text", "caption": null, "header_text": ""}, {"table_index": 6, "table_type": "exhibit_index", "caption": null, "header_text": ""}, {"table_index": 7, "table_type": "financial", "caption": null, "header_text": ""}, {"table_index": 8, "table_type": "financial", "caption": null, "header_text": ""}, {"table_index": 9, "table_type": "financial", "caption": null, "header_text": ""}, {"table_index": 10, "table_type": "financial", "caption": null, "header_text": ""}, {"table_index": 11, "table_type": "financial", "caption": null, "header_text": ""}, {"table_index": 12, "table_type": "financial", "caption": null, "header_text": ""}, {"table_index": 13, "table_type": "financial", "caption": null, "header_text": ""}, {"table_index": 14, "table_type": "financial", "caption": null, "header_text": ""}, {"table_index": 15, "table_type": "financial", "caption": null, "header_text": ""}, {"table_index": 16, "table_type": "text", "caption": null, "header_text": ""}, {"table_index": 17, "table_type": "financial", "caption": null, "header_text": ""}, {"table_index": 18, "table_type": "financial", "caption": null, "header_text": ""}, {"table_index": 19, "table_type": "text", "caption": null, "header_text": ""}, {"table_index": 20, "table_type": "text", "caption": null, "header_text": ""}, {"table_index": 21, "table_type": "text", "caption": null, "header_text": ""}, {"table_index": 22, "table_type": "financial", "caption": null, "header_text": ""}, {"table_index": 23, "table_type": "financial", "caption": null, "header_text": ""}, {"table_index": 24, "table_type": "financial", "caption": null, "header_text": ""}, {"table_index": 25, "table_type": "financial", "caption": null, "header_text": ""}, {"table_index": 26, "table_type": "text", "caption": null, "header_text": ""}, {"table_index": 27, "table_type": "financial", "caption": null, "header_text": ""}, {"table_index": 28, "table_type": "financial", "caption": null, "header_text": ""}, {"table_index": 29, "table_type": "financial", "caption": null, "header_text": ""}, {"table_index": 30, "table_type": "financial", "caption": null, "header_text": ""}, {"table_index": 31, "table_type": "financial", "caption": null, "header_text": ""}, {"table_index": 32, "table_type": "financial", "caption": null, "header_text": ""}, {"table_index": 33, "table_type": "text", "caption": null, "header_text": ""}, {"table_index": 34, "table_type": "exhibit_index", "caption": null, "header_text": ""}, {"table_index": 35, "table_type": "exhibit_index", "caption": null, "header_text": ""}, {"table_index": 36, "table_type": "text", "caption": null, "header_text": ""}], "exhibits_pending": false, "cdn_html": true, "response_time_ms": 24}